Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials
Explore this paper's citation graph
Summary
A standardized approach to PRO assessment in MS research is suggested and 2 generic, National Institutes of Health-supported measurement systems that would facilitate such an approach are described.
- Type
- review
- Published
- 2017-09-14
- Cited by
- 68
- References
- 131
- Access
- Open access
- OpenAlex
- https://openalex.org/W2755388157
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:21873059
Keywords
Medicine, Clinical trial, Quality of life (healthcare), Teriflunomide, Multiple sclerosis
References
- Capturing patients' perspectives of treatment in clinical trials/drug development.
- Outcome Measures in Clinical Trials for Multiple Sclerosis
- Health-related quality of life assessment in multiple sclerosis.
- Quality of Life in People with Multiple Sclerosis: Data from the Sonya Slifka Longitudinal Multiple Sclerosis Study
- Drug points: Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment
- Response to Hays et al and McHorney and Cohen: A Discussion of Item Response Theory and Its Applications in Health Status Assessment
- A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure.
- Health status assessment for the twenty-first century: item response theory, item banking and computer adaptive testing
- Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.
- The PROMIS of QALYs
- Validating Neuro-QoL Short Forms and Targeted Scales with Persons who have Multiple Sclerosis
- Inpatient rehabilitation in multiple sclerosis
- The World Health Organization WHOQOL-100: tests of the universality of Quality of Life in 15 different cultural groups worldwide.
- Health-Related Quality of Life in Multiple Sclerosis
- Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
- The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
- Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
- The impact of next and back buttons on time to complete and measurement reliability in computer-based surveys
- Neuro-QOL
- Disease-related determinants of quality of life 10 years after clinically isolated syndrome.
Cited by
- Treatment with the monoclonal antibody rituximab in Multiple Sclerosis : a study based on an academic clinical trial
- Patient‐reported outcomes are worse for progressive‐onset multiple sclerosis than relapse‐onset multiple sclerosis, particularly early in the disease process
- Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60.
- Review: Patient-reported outcomes in multiple sclerosis care.
- Life domains that are important to quality of life for people with multiple sclerosis: A population-based qualitative analysis
- Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported Outcomes
- Interactive Visual Analysis of Patient-Reported Outcomes for Improved Cancer Aftercare
- Individualised behaviour change strategies for physical activity in multiple sclerosis (IPAC-MS): protocol for a randomised controlled trial
- Validation of 0-10 MS symptom scores in the Australian multiple sclerosis longitudinal study.
- Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
- Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes
- Patient Reported Outcomes Measures in Colon and Rectal Surgery: A Systematic Review and Quality Assessment
- A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple Sclerosis
- Der Patient als Experte
- Reliability and Validity of the Lower-Extremity Motor Activity Log (LE-MAL) for Measuring Real-world Leg-Use in Adults with Multiple Sclerosis.
- Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
- Patients and neurologists have different perceptions of multiple sclerosis symptoms, care and challenges.
- The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study
- Retention of Physical Gains in the Community Following Physical Training for Multiple Sclerosis: A Systematic Review and Implications
- Integrating patient-reported outcomes and quantitative timed tasks to identify relapsing remitting multiple sclerosis patient subgroups: a latent profile analysis.
Related papers
- Some risk management issues in teriflunomide treatment of patients with remitting multiple sclerosis
- Recent advance in disease-modifying drugs for multiple sclerosis
- Daclizumab/interferon-β-1a/teriflunomide
- Current and Future Therapies for Multiple Sclerosis
- New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis.
- Current and Future Role of Interferon Beta in the Therapy of Multiple Sclerosis
- Immune therapy of multiple sclerosis--future strategies.
- Advances in the treatment of multiple sclerosis
- New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come